Yujiro Hata, vice president of corporate development, Onyx Pharmaceuticals
Daniel Hicklin, oncology research, Merck
Henry Hoehn, associate director, metrology, ImClone Systems, a subsidiary of Eli Lilly
Andrea Hooper, senior research scientist, Pfizer
Kiyoung Hong, manager, regulatory submissions, Regeneron Pharmaceuticals
Abe Horowitz, senior director, information technologies, Kadmon Pharmaceuticals
Michael Howerton, executive vice president, chief operating officer, Kadmon Pharmaceuticals
Jim Huber, project manager, ImClone Systems, a subsidiary of Eli Lilly
Carl Icahn, chairman, Icahn Enterprises
Saji Jacob, executive director, cGMP Validation
Ishrat-Mira Jahan, lab systems engineer, Regeneron Pharmaceuticals
John H. Johnson, CEO, Savient Pharmaceuticals
Joe Kamienski, finance director, supply chain, ImClone Systems, a subsidiary of Eli Lilly
Carolyn Keller-Bogemans, director, sales operations, Allos Therapeutics
Adam Kiernan, systems consultant, JM Huber
Jason Kim, chief financial officer, Molecular Templates
Eric Kizmann, internal audit, compliance and project director, ImClone Systems, a subsidiary of Eli Lilly
Glenn Kupsch, associate vice president of IT operations, ImClone Systems, a subsidiary of Eli Lilly
William Liao, co-founder, chief business officer, Primrose Therapeutics
Monica Lin, associate director, training & learning stragies, ImClone Systems, a subsidiary of Eli Lilly
Hu Liu, principal scientist, Pfizer
Vienna Lo, scientist, Celgene
Linda Louie, HR professional
Jason Lu, chemical and pharmaceutical professional
Dale Ludwig, vice president of research/biologics technology, ImClone Systems, a subsidiary of Eli Lilly
Xenia Luna, scientist, Kadmon Pharmaceuticals
Daniel Lynch, executive chairman, Avila Therapeutics, executive chairman, Stromedix
Cheryl Maiello, manager of global development staffing, Novartis
Anne Marra, senior director, regulatory operations, NPS Pharmaceuticals
Ron Martell, CEO, Poniard Pharmaceuticals
James Mastridge, director of financial reporting, ImClone Systems, a subsidiary of Eli Lilly
Greg Mayes, vice president of corporate development, general counsel, Unigene Laboratories
Josh Meier, biotechnology professional
